Transplant-Related Malignant Neoplasm — Trials

Transplant-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

13 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Center for International Blood and Marrow Transplant Research
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03963024	Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT(TrRaMM-TMI)	terminated	Phase 1	9	IRCCS San RaffaeleOTHER	1	Oct 19, 2020	clinicaltrials
NCT01282216	Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide	terminated	Phase 2	120	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	1	May 30, 2019